AbbVie (NYSE:ABBV) reported quarterly earnings of $2.71 per share which beat the analyst consensus estimate of $2.65 by 2.19 percent. This is a 25.46 percent increase over earnings of $2.16 per share from the same period last year. The company reported quarterly sales of $16.618 billion which beat the analyst consensus estimate of $16.421 billion by 1.20 percent. This is a 10.04 percent increase over sales of $15.102 billion the same period last year.